14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of PLRX
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

A very strong day for Pliant Therapeutics Inc. stock price on Wednesday
(Updated on May 01, 2024)

Hold candidate since May 01, 2024 PDF

The Pliant Therapeutics Inc. stock price gained 7.11% on the last trading day (Wednesday, 1st May 2024), rising from $11.82 to $12.66. During the last trading day the stock fluctuated 9.80% from a day low at $11.73 to a day high of $12.88. The price has fallen in 6 of the last 10 days and is down by -1.56% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 200 thousand more shares were traded than the day before. In total, 679 thousand shares were bought and sold for approximately $8.59 million.

The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -25.56% during the next 3 months and, with a 90% probability hold a price between $8.62 and $10.22 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

PLRX Signals & Forecast

A buy signal was issued from a pivot bottom point on Friday, April 26, 2024, and so far it has risen 7.20%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Pliant Therapeutics Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $13.85. On a fall, the stock will find some support from the short-term average at $12.10. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Pliant Therapeutics Inc. stock

Pliant Therapeutics Inc. finds support from accumulated volume at $12.52 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $1.15 between high and low, or 9.80%. For the last week, the stock has had daily average volatility of 5.65%.

Our recommended stop-loss: $12.11 (-4.38%) (This stock has high daily movements and this gives high risk. There is a buy signal from a pivot bottom found 3 days ago.)

Trading Expectations (PLRX) For The Upcoming Trading Day Of Thursday 2nd

For the upcoming trading day on Thursday, 2nd we expect Pliant Therapeutics Inc. to open at $12.42, and during the day (based on 14 day Average True Range), to move between $12.00 and $13.32, which gives a possible trading interval of +/-$0.664 (+/-5.24%) up or down from last closing price. If Pliant Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 10.49% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $12.52 (1.11%) than the resistance at $14.65 (15.72%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Pliant Therapeutics Inc. stock A Buy?

Pliant Therapeutics Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

Current score: -0.773 Hold/Accumulate Upgraded

Predicted Opening Price for Pliant Therapeutics Inc. of Thursday, May 2, 2024

Fair opening price May 2, 2024 Current price
$12.42 ( 1.87%) $12.66

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for PLRX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 13.57 7.21 %
R2 13.13 3.74 %
R1 12.86 1.60 %
Current price: 12.66
Support S1 11.98 -5.34 %
S2 11.71 -7.48 %
S3 11.27 -10.95 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 15.80 24.80 %
R2 14.90 17.69 %
R1 14.65 15.72 %
Current price 12.66
Support S1 12.52 -1.11%
S2 11.88 -6.16%
S3 11.82 -6.64%

FAQ

What is the symbol for Pliant Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Pliant Therapeutics Inc. is PLRX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Pliant Therapeutics Inc. Stock?
Pliant Therapeutics Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

How to buy Pliant Therapeutics Inc. Stock?
Pliant Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Pliant Therapeutics Inc. Stock.

What's the current price of Pliant Therapeutics Inc. Stock?
As of the end of day on the May 01, 2024, the price of an Pliant Therapeutics Inc. (PLRX) share was $12.66.

What is the 52-week high and low for Pliant Therapeutics Inc. Stock?
The 52-week high for Pliant Therapeutics Inc. Stock is $24.74 and the 52-week low is $11.21.

What is the market capitalization of Pliant Therapeutics Inc. Stock?
As of the May 01, 2024, the market capitalization of Pliant Therapeutics Inc. is 763.635M.

When is the next earnings date for Pliant Therapeutics Inc.?
The upcoming earnings date for Pliant Therapeutics Inc. is May 14, 2024.
Click to get the best stock tips daily for free!

About Pliant Therapeutics Inc.

Pliant Therapeutics. Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a trials. The company also develops PLN-1474, a small-molecule selective inhibitor of avß1, which complet... PLRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT